Full Text View
Tabular View
No Study Results Posted
Related Studies
Esomeprazole in PPI Failures - IMPROVE
This study has been completed.
Study NCT00272701   Information provided by AstraZeneca

First Received on January 4, 2006.   Last Updated on March 5, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gastroesophageal Reflux Disease
Additional conditions recognized in this trial
Gastroesophageal Reflux
More general conditions related to this trial
Deglutition Disorders
Digestive System Diseases
Esophageal Diseases
Esophageal Motility Disorders
Gastrointestinal Diseases
Interventions listed in this trial
Esomeprazole
Other PPI marketed in Sweden
Additional drug interventions recognized in this trial
Omeprazole
Proton Pump Inhibitors
More general drug interventions related to this trial
Anti-Ulcer Agents
Enzyme Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services